Other Name(s): BCL-XL, Bcl-xL, BCLXL
Assay:Inhibitory concentration against B-Cell Lymphoma xL (Bcl-xL) Bak-peptide binding region
Type:IC50
SMILES:CN(C)CCC=C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Value:=180000nM
Source:
Assay:Inhibitory concentration against B-Cell Lymphoma xL (Bcl-xL) Bak-peptide binding region
Type:IC50
SMILES:CN(C)CC/C=C(\c1ccc(Cl)cc1)c1ccc(CCCc2ccc(/C(=C\CCN(C)C)c3ccc(Cl)cc3)cc2)cc1
Value:=10000nM
Source:
Assay:Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide
Type:Ki
SMILES:COC(=O)[C@H](CC(C)C)NC(=O)c1ccc(C(=O)N(C(C)C)C(C)C)cc1OC(C)C
Value:=781nM
Source:
Assay:Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide
Type:Ki
SMILES:COC(=O)[C@@H](CC(C)C)NC(=O)c1ccc(C(=O)N(C(C)C)C(C)C)cc1OC
Value:=1785nM
Source:
Assay:Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide
Type:Ki
SMILES:CC(C)C[C@H](NC(=O)c1ccc(C(=O)N(CC(C)C)C(C(=O)O)C(C)C)cc1OC(C)C)C(=O)O
Value:>30000nM
Source:
Assay:Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide
Type:Ki
SMILES:CC(C)C[C@H](NC(=O)c1ccc(C(=O)N(C(C)C)C(C)C)cc1OC(C)C)C(=O)O
Value:=839nM
Source:
Assay:Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide
Type:Ki
SMILES:CC(C)C[C@H](NC(=O)c1ccc(C(=O)N(C(C)C)C(C)C)cc1Oc1cccc2ccccc12)C(=O)O
Value:=7631nM
Source:
Assay:Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide
Type:Ki
SMILES:CC(C)C[C@H](NC(=O)c1ccc(C(=O)N(C(C)C)C(C)C)cc1NC(C)C)C(=O)O
Value:=3313nM
Source:
Assay:Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide
Type:Ki
SMILES:CC(C)CC(NC(=O)c1ccc(C(=O)N[C@@H](CC(C)C)C(=O)O)c(Oc2cccc3ccccc23)c1)C(=O)O
Value:>30000nM
Source:
Assay:Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide
Type:Ki
SMILES:COC(=O)CNC(=O)c1ccc(C(=O)N(C)C)cc1
Value:>30000nM
Source:
Assay:Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide
Type:Ki
SMILES:COC(=O)[C@H](CC(C)C)NC(=O)c1ccc(C(=O)N(C(C)C)C(C)C)cc1OC
Value:=1852nM
Source:
Assay:Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide
Type:Ki
SMILES:COC(=O)[C@@H](NC(=O)c1ccc(C(=O)N(C(C)C)C(C)C)cc1OC(C)C)C(C)C
Value:=5846nM
Source:
Assay:Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide
Type:Ki
SMILES:CC(C)C[C@H](NC(=O)c1ccc(C(=O)N(CC(C)C)C(C)C(=O)O)cc1OC(C)C)C(=O)O
Value:>30000nM
Source:
Assay:Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide
Type:Ki
SMILES:COC(=O)[C@@H](NC(=O)c1ccc(C(=O)N(C(C)C)C(C)C)cc1OC(C)C)c1ccccc1
Value:=10920nM
Source:
Assay:Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide
Type:Ki
SMILES:CC(C)CC(NC(=O)c1ccc(C(=O)N[C@@H](CC(C)C)C(=O)O)c(Oc2ccccc2)c1)C(=O)O
Value:>30000nM
Source:
Assay:Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide
Type:Ki
SMILES:COC(=O)[C@H](C)NC(=O)c1ccc(C(=O)N(C(C)C)C(C)C)cc1OC(C)C
Value:=10960nM
Source:
Assay:Binding affinity for Bcl-xL was assessed by a fluorescence polarization assay using a fluorescently labeled 16-mer Bak-peptide
Type:Ki
SMILES:CC(C)C[C@H](NC(=O)c1ccc(C(=O)N(C(C)C)C(C)C)cc1Oc1ccccc1)C(=O)O
Value:=1013nM
Source:
Assay:Inhibitory concentration against Bcl-xl
Type:IC50
SMILES:COC(=O)c1cc(O)c(=O)c2cc(O)c(O)cc2c1
Value:=2600nM
Source:Homo sapiens
Assay:Inhibitory concentration against Bcl-xl
Type:IC50
SMILES:COc1c(O)cc2cccc(OC)c(=O)c2c1OC
Value:>100000nM
Source:Homo sapiens
Assay:Inhibitory concentration against Bcl-xl
Type:IC50
SMILES:COc1cc2cccc(OC)c(=O)c2c(OC)c1OC
Value:>100000nM
Source:Homo sapiens

Note: If you'd like to learn how our AI-powered BDE-Chem can help design therapeutic molecules against the BCL2L1 target, that break through the existing patents, at a cost 90% lower than traditional approaches, please feel free to contact us at BD@silexon.ai

Molecules for More Common Targets

ABCB1 | ABCG2 | ACE2 | AHR | AKT1 | ALK | AR | ATM | BAX | BCL2 | BCL2L1 | BRAF | BRCA1 | CASP3 | CASP9 | CCL5 | CCND1 | CD274 | CD4 | CDKN1A | CXCL8 | CXCR4 | DNMT1 | EGF | EGFR | EP300 | ERBB2 | ESR1 | EZH2 | FN1 | FOXO3 | HDAC9 | HGF | HMGB1 | HSP90AA1 | HSPA5 | IDO1 | IGF1 | IGF1R | IL17A | IL6 | INS | JUN | KRAS | MAPK1 | MAPK14 | MAPK3 | MAPK8 | MAPT | MCL1 | MMP9 | MTOR | MYC | NFE2L2 | NLRP3 | NOTCH1 | PARP1 | PCNA | PDCD1 | PLK1 | PRKAA1 | PRKAA2 | PTEN | PTGS2 | PTK2 | RELA | SIRT1 | SRC | STAT1 | STAT3 | STAT5A | TERT | TLR4 | TNF | TP53 | TXN | VEGFA | YAP1